Effects of Tafluprost on Ocular Blood Flow

被引：0
作者：
Xinyue Zhang
Xiaoyu Zhou
Yang Zhao
Xiang Yang
Dengming Zhou
Baihua Chen
Xuanchu Duan
机构：
[1] Changsha Aier Eye Hospital,Aier School of Ophthalmology
[2] The Second Xiangya Hospital,undefined
[3] Central South University,undefined
[4] Central South University,undefined
来源：
Ophthalmology and Therapy | 2022年 / 11卷
关键词：
Tafluprost; Prostaglandin analogues; Ocular blood flow; Microcirculation; Glaucoma;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Increasing evidence indicates that improving ocular blood flow (OBF) can be a therapeutic direction for glaucoma therapy. Tafluprost, a prostaglandin analogue which lowers the intraocular pressure (IOP), has been shown to improve OBF in animals and humans. Several animal experiments showed that topical tafluprost significantly increased optic nerve head and retinal blood flow. Clinical trials also showed a beneficial effect of tafluprost on optic nerve head and macula blood flow, and a good ocular pulse amplitude-lowering effect. But, there are still a few conflicting results. Overall, tafluprost seems to have a beneficial effect on OBF, and the positive effect is probably independent from its IOP-lowering effect, which also is expected to improve OBF. Moreover, reducing the intracellular free Ca2+ concentration may be a possible mechanism of tafluprost’s effect on OBF. More well-designed studies are required to reveal the truth.
引用
收藏
页码：1991 / 2003
页数：12
相关论文
共 230 条
  • [21] Kuerten D(2003)New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents Biol Pharm Bull 78 2006-2011
  • [22] Fuest M(2004)Pharmacological characteristics of AFP-168 (tafluprost), a new prostanoid FP receptor agonist, as an ocular hypotensive drug Exp Eye Res 17 97-104
  • [23] Koch EC(2001)Preclinical efficacy of travoprost, a potent and selective FP prostaglandin receptor agonist J Ocul Pharmacol Ther 46 221-235
  • [24] Koutsonas A(2005)Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation Invest Ophthalmol Vis Sci 26 359-365
  • [25] Plange N(2010)A phase II study on the duration and stability of the intraocular pressure-lowering effect and tolerability of tafluprost compared with latanoprost J Ocul Pharmacol Ther 34 511-528
  • [26] Shin JD(2017)24-hour efficacy and ocular surface health with preservative-free tafluprost alone and in conjunction with preservative-free dorzolamide/timolol fixed combination in open-angle glaucoma patients insufficiently controlled with preserved latanoprost monotherapy Adv Ther 23 521-526
  • [27] Wolf AT(2007)A comparative, placebo-controlled study of prostanoid fluoroprostaglandin-receptor agonists tafluprost and latanoprost in healthy males J Ocul Pharmacol Ther 26 459-496
  • [28] Harris A(2010)Mixed treatment comparison and meta-regression of the efficacy and safety of prostaglandin analogues and comparators for primary open-angle glaucoma and ocular hypertension Curr Med Res Opin 24 455-460
  • [29] Shoji T(2008)Short-term effects of topical tafluprost on retinal blood flow in cats J Ocul Pharmacol Ther 19 251-256
  • [30] Zangwill LM(2000)Microvascular effects of selective prostaglandin analogues in the eye with special reference to latanoprost and glaucoma treatment Prog Retin Eye Res 76 181-186
12345678910